Author
Listed:
- Qipan Deng
(Section of Epidemiology and Population Sciences, Baylor College of Medicine
Lerner Research Institute, Cleveland Clinic)
- Hui Hu
(Lerner Research Institute, Cleveland Clinic
Central Hospital of Wuhan)
- Xinfang Yu
(Section of Epidemiology and Population Sciences, Baylor College of Medicine
Lerner Research Institute, Cleveland Clinic)
- Shuanglin Liu
(Section of Epidemiology and Population Sciences, Baylor College of Medicine
Lerner Research Institute, Cleveland Clinic)
- Lei Wang
(Lerner Research Institute, Cleveland Clinic)
- Weiqun Chen
(Central Hospital of Wuhan)
- Chi Zhang
(Central Hospital of Wuhan)
- Zhaoyang Zeng
(Lerner Research Institute, Cleveland Clinic
Central South University; Key Laboratory of Carcinogenesis, Chinese Ministry of Health)
- Ya Cao
(Central South University; Key Laboratory of Carcinogenesis, Chinese Ministry of Health)
- Zijun Y. Xu-Monette
(Division of Hematopathology, Duke University Medical Center)
- Ling Li
(the First Affiliated Hospital of Zhengzhou University; Lymphoma Diagnosis and Treatment Center of Henan Province)
- Mingzhi Zhang
(the First Affiliated Hospital of Zhengzhou University; Lymphoma Diagnosis and Treatment Center of Henan Province)
- Steven Rosenfeld
(Lerner Research Institute, Cleveland Clinic)
- Shideng Bao
(Lerner Research Institute, Cleveland Clinic)
- Eric Hsi
(Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic)
- Ken H. Young
(Division of Hematopathology, Duke University Medical Center)
- Zhongxin Lu
(Central Hospital of Wuhan)
- Yong Li
(Section of Epidemiology and Population Sciences, Baylor College of Medicine
Lerner Research Institute, Cleveland Clinic)
Abstract
A noncoding polymorphism (rs78378222) in TP53, carried by scores of millions of people, was previously associated with moderate risk of brain tumors and other neoplasms. We find a positive association between this variant and soft tissue sarcoma. In sharp contrast, it is protective against breast cancer. We generated a mouse line carrying this variant and found that it accelerates spontaneous tumorigenesis and glioma development, but strikingly, delays mammary tumorigenesis. The variant creates a miR-382-5p targeting site and compromises a miR-325-3p site. Their differential expression results in p53 downregulation in the brain, but p53 upregulation in the mammary gland of polymorphic mice compared to that of wild-type littermates. Thus, this variant is at odds with Li-Fraumeni Syndrome mutants in breast cancer predisposition yet consistent in glioma predisposition. Our findings elucidate an underlying mechanism of cancer susceptibility that is conferred by genetic variation and yet altered by microRNA expression.
Suggested Citation
Qipan Deng & Hui Hu & Xinfang Yu & Shuanglin Liu & Lei Wang & Weiqun Chen & Chi Zhang & Zhaoyang Zeng & Ya Cao & Zijun Y. Xu-Monette & Ling Li & Mingzhi Zhang & Steven Rosenfeld & Shideng Bao & Eric H, 2019.
"Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant,"
Nature Communications, Nature, vol. 10(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13002-x
DOI: 10.1038/s41467-019-13002-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13002-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.